Media release – 22 June 2015 Arthritis Australia is concerned that patient safety may be compromised by current moves in Australia to allow biosimilars to be substituted for biologic medications at the pharmacy level.  Click here to download the full media release Biologic medications are used to treat a number of auto-immune forms of arthritis, … Continue reading Public safety must not be pushed sside in Government quest for Biosimilar budget savings